News
Zacks Investment Research on MSN1d
Vertex Pharmaceuticals Incorporated (VRTX) is Attracting Investor Attention: Here is What You Should KnowVertex Pharmaceuticals (VRTX) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's ...
StockStory.org on MSN2d
Vertex Pharmaceuticals (VRTX): Buy, Sell, or Hold Post Q1 Earnings?Vertex Pharmaceuticals trades at $469.50 and has moved in lockstep with the market. Its shares have returned 6.5% over the ...
Researchers at Vanderbilt University have found that boosting a signaling pathway in the brain can prolong ketamine’s antidepressant effects, at least in mice. The team found that compared with ...
How will FDA changes reshape drug approval in 2025 and beyond? Vaccines and complex biologics may face greater headwinds as processes change at a short-staffed agency ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback